FGFR2 and breast cancer: Since FGFR signalling, and FGFR2 in particular, has been implicated as a driving force in breast cancer [6], over-expression of FGFR2 as a result of such alterations in transcriptional regulation was postulated as the underlying cause of the increased risk of developing breast cancer.